Revision Skincare Validates Vitamin C Serum in Clinical Studies
IRVING, Texas, April 9, 2026 Revision Skincare® has announced the publication of two peer-reviewed clinical studies in the Journal...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Ophthalmology Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Cosmetics Products, Ingredients, and Potential Contaminants.
IRVING, Texas, April 9, 2026 Revision Skincare® has announced the publication of two peer-reviewed clinical studies in the Journal...
NEW DELHI, India, April 3, 2026 Kama Ayurveda has announced the launch of its Sandanya anti-blemish skincare collection, marking...
SANTA MONICA, Calif., March 30, 2026 Beyond Facials, an advanced skincare innovation studio, has introduced its latest breakthrough treatment,...
Cologne, March 16, 2026 LANXESS announced its participation at the in-cosmetics Global 2026, scheduled from April 14 to 16...
NEW YORK, March 2, 2026 Hairitage by Mindy, the inclusive haircare brand founded by digital creator Mindy McKnight, has...
DALLAS, Feb. 20, 2026 — Revision Skincare® announced that its DEJ Daily Boosting Serum™ has been named Winner in...
Sacramento, California | February 19, 2026 — KilgourMD announced results from an independent Phase II clinical trial evaluating its...
NEW YORK, Feb. 12, 2026 — The Hair Edit has launched a new portfolio of ultra-concentrated hair care formulations...
Lewes, Delaware — February 10, 2026: The global Cosmetovigilance Market is entering a high-growth phase driven by intensifying regulatory...
ZUG, Switzerland, January 29, 2026 — Galderma, the global pure-play dermatology leader, has unveiled ‘Wake Up To Restylane®’, a...
